Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis

被引:99
作者
Baskol, Gulden [1 ]
Baskol, Mevlut
Kocer, Derya
机构
[1] Erciyes Univ, Fac Med, Dept Biochem & Clin Biochem, Kayseri, Turkey
[2] Erciyes Univ, Fac Med, Dept Gastroenterol, Kayseri, Turkey
关键词
non-alcoholic steatohepatitis; superoxide dismutase; nitric oxide; paraoxonase;
D O I
10.1016/j.clinbiochem.2007.02.006
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Oxidative stress is an important pathophysiological mechanism in non-alcoholic steatohepatitis (NASH). We aimed to evaluate serum xanthine oxidase (XO) (as a generator of reactive oxygen species), superoxide dismutase (SOD), glutathione peroxidase (GSHPx), paraoxonase (PON1) activities, nitric oxide (NO) and thiol levels in patients with NASH. Design and methods: A total of 35 patients with NASH and 31 age-and-gender-matched healthy subjects were enrolled in the study as control group. Serum levels of XO, NO, SOD, GSHPx, PON1 and thiol were determined by spectrophotometric methods. Results: Serum XO activities were higher in the patients with NASH than the controls (p < 0.001). Serum NO levels, SOD, GSHPx, PON1 activities and thiol levels were lower in the patients with NASH than the controls (p < 0.031, p < 0.019, p < 0.001, p < 0.001, p < 0.001, respectively). Conclusions: Increased oxidative stress in patients with NASH may result in a pro-oxidation environment, which in turn could result in decreased antioxidant enzyme activities and NO levels. Therefore effective antioxidant therapy to inhibit oxidative stress is necessary and agents to increase antioxidant enzyme may be a therapeutic option in NASH. (c) 2007 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:776 / 780
页数:5
相关论文
共 40 条
[1]   Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants [J].
Aviram, M ;
Rosenblat, M ;
Billecke, S ;
Erogul, J ;
Sorenson, R ;
Bisgaier, CL ;
Newton, RS ;
La Du, B .
FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (7-8) :892-904
[2]   Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase [J].
Aviram, M ;
Rosenblat, M ;
Bisgaier, CL ;
Newton, RS ;
Primo-Parmo, SL ;
La Du, BN .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1581-1590
[3]   Serum paraoxonase after myocardial infarction [J].
Ayub, A ;
Mackness, MI ;
Arrol, S ;
Mackness, B ;
Patel, J ;
Durrington, PN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (02) :330-335
[4]   Serum paraoxonase 1 activity and lipid peroxidation levels in patients with age-related macular degeneration [J].
Baskol, G ;
Karakucuk, S ;
Oner, AO ;
Baskol, M ;
Kocer, D ;
Mirza, E ;
Saraymen, R ;
Üstdal, M .
OPHTHALMOLOGICA, 2006, 220 (01) :12-16
[5]   Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis [J].
Baskol, G ;
Demir, H ;
Baskol, M ;
Kilic, E ;
Ates, F ;
Kocer, D ;
Muhtaroglu, S .
CLINICAL BIOCHEMISTRY, 2005, 38 (10) :951-955
[6]   Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis [J].
Baskol, Gulden ;
Baskol, Mevlut ;
Yurci, Alper ;
Ozbakir, Omer ;
Yucesoy, Mehmet .
CELL BIOCHEMISTRY AND FUNCTION, 2006, 24 (03) :283-286
[7]  
Baskol Mevlut, 2005, Turk J Gastroenterol, V16, P119
[8]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[9]  
BORIES PN, 1995, CLIN CHEM, V41, P904
[10]   Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions [J].
Brunt, EM ;
Janney, CG ;
Di Bisceglie, AM ;
Neuschwander-Tetri, BA ;
Bacon, BR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) :2467-2474